Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
Two patients with a widespread thyroid medullary carcinoma were treated with [131I]metaiodobenzylguanidine. This treatment failed, due to the fact that the majority of the metastases did not take up the tracer.
Schvartz
C
C
Nuclear Medicine Service, Institut Jean Godinot, Reims, France.
Delisle
M J
MJ
D019797:3-Iodobenzylguanidine; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine